Maternal Race and Clinical Vigilance in Obstetric Hemorrhage Management
<b>Background/Objectives:</b> Previous literature has described that non-white pregnant patients are at increased risk of severe morbidity from obstetric hemorrhage (OBH). Here, we investigate whether such disparities are secondary to delay in the administration of postpartum oxytocin fo...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Reproductive Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-3897/6/1/1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850279793531027456 |
|---|---|
| author | Michelle Joy Wang Megan V. Alexander Akanksha Srivastava Diana Abbas Sara Young Swetha Tummala Lindsey Claus Ronald Iverson Ashley Comfort Christina D. Yarrington |
| author_facet | Michelle Joy Wang Megan V. Alexander Akanksha Srivastava Diana Abbas Sara Young Swetha Tummala Lindsey Claus Ronald Iverson Ashley Comfort Christina D. Yarrington |
| author_sort | Michelle Joy Wang |
| collection | DOAJ |
| description | <b>Background/Objectives:</b> Previous literature has described that non-white pregnant patients are at increased risk of severe morbidity from obstetric hemorrhage (OBH). Here, we investigate whether such disparities are secondary to delay in the administration of postpartum oxytocin for non-white patients compared to white patients. <b>Methods:</b> This is a retrospective cohort study of all deliveries from 2018 to 2019, comparing (1) Hispanic white or non-white race (HW/NWR) pregnant people and (2) non-Hispanic white (NHW) pregnant people. Our primary outcome was the time from delivery to the first dose of postpartum oxytocin, and our secondary outcome was the frequency of other hemorrhage interventions. <b>Results:</b> Out of 3832 patients with self-identified race and ethnicity recorded in their patient record, 644 patients identified as NHW, and 3188 patients identified as HW/NWR. We found no difference in time to first dose of postpartum oxytocin (<i>p</i> = 0.51), and there was also no difference in the frequency of other hemorrhage-related interventions. <b>Conclusions:</b> Our study found no delay in the administration of postpartum oxytocin for non-white patients. |
| format | Article |
| id | doaj-art-df7c718476d24b859e225a79dbe8db21 |
| institution | OA Journals |
| issn | 2673-3897 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Reproductive Medicine |
| spelling | doaj-art-df7c718476d24b859e225a79dbe8db212025-08-20T01:48:58ZengMDPI AGReproductive Medicine2673-38972025-01-0161110.3390/reprodmed6010001Maternal Race and Clinical Vigilance in Obstetric Hemorrhage ManagementMichelle Joy Wang0Megan V. Alexander1Akanksha Srivastava2Diana Abbas3Sara Young4Swetha Tummala5Lindsey Claus6Ronald Iverson7Ashley Comfort8Christina D. Yarrington9Beth Israel Deaconess Medical Center, Department of Obstetrics and Gynecology, KS3, 330 Brookline Avenue, Boston, MA 02118, USABoston Medical Center, Department of Obstetrics and Gynecology, 850 Harrison Avenue, Boston, MA 02118, USABoston Medical Center, Department of Obstetrics and Gynecology, 850 Harrison Avenue, Boston, MA 02118, USABoston Medical Center, Department of Obstetrics and Gynecology, 850 Harrison Avenue, Boston, MA 02118, USABoston Medical Center, Department of Obstetrics and Gynecology, 850 Harrison Avenue, Boston, MA 02118, USABoston Medical Center, Department of Obstetrics and Gynecology, 850 Harrison Avenue, Boston, MA 02118, USABoston Medical Center, Department of Obstetrics and Gynecology, 850 Harrison Avenue, Boston, MA 02118, USABoston Medical Center, Department of Obstetrics and Gynecology, 850 Harrison Avenue, Boston, MA 02118, USABeth Israel Deaconess Medical Center, Department of Obstetrics and Gynecology, KS3, 330 Brookline Avenue, Boston, MA 02118, USABoston Medical Center, Department of Obstetrics and Gynecology, 850 Harrison Avenue, Boston, MA 02118, USA<b>Background/Objectives:</b> Previous literature has described that non-white pregnant patients are at increased risk of severe morbidity from obstetric hemorrhage (OBH). Here, we investigate whether such disparities are secondary to delay in the administration of postpartum oxytocin for non-white patients compared to white patients. <b>Methods:</b> This is a retrospective cohort study of all deliveries from 2018 to 2019, comparing (1) Hispanic white or non-white race (HW/NWR) pregnant people and (2) non-Hispanic white (NHW) pregnant people. Our primary outcome was the time from delivery to the first dose of postpartum oxytocin, and our secondary outcome was the frequency of other hemorrhage interventions. <b>Results:</b> Out of 3832 patients with self-identified race and ethnicity recorded in their patient record, 644 patients identified as NHW, and 3188 patients identified as HW/NWR. We found no difference in time to first dose of postpartum oxytocin (<i>p</i> = 0.51), and there was also no difference in the frequency of other hemorrhage-related interventions. <b>Conclusions:</b> Our study found no delay in the administration of postpartum oxytocin for non-white patients.https://www.mdpi.com/2673-3897/6/1/1quantitative blood lossmaternal morbiditypostpartum oxytocinpregnancy |
| spellingShingle | Michelle Joy Wang Megan V. Alexander Akanksha Srivastava Diana Abbas Sara Young Swetha Tummala Lindsey Claus Ronald Iverson Ashley Comfort Christina D. Yarrington Maternal Race and Clinical Vigilance in Obstetric Hemorrhage Management Reproductive Medicine quantitative blood loss maternal morbidity postpartum oxytocin pregnancy |
| title | Maternal Race and Clinical Vigilance in Obstetric Hemorrhage Management |
| title_full | Maternal Race and Clinical Vigilance in Obstetric Hemorrhage Management |
| title_fullStr | Maternal Race and Clinical Vigilance in Obstetric Hemorrhage Management |
| title_full_unstemmed | Maternal Race and Clinical Vigilance in Obstetric Hemorrhage Management |
| title_short | Maternal Race and Clinical Vigilance in Obstetric Hemorrhage Management |
| title_sort | maternal race and clinical vigilance in obstetric hemorrhage management |
| topic | quantitative blood loss maternal morbidity postpartum oxytocin pregnancy |
| url | https://www.mdpi.com/2673-3897/6/1/1 |
| work_keys_str_mv | AT michellejoywang maternalraceandclinicalvigilanceinobstetrichemorrhagemanagement AT meganvalexander maternalraceandclinicalvigilanceinobstetrichemorrhagemanagement AT akankshasrivastava maternalraceandclinicalvigilanceinobstetrichemorrhagemanagement AT dianaabbas maternalraceandclinicalvigilanceinobstetrichemorrhagemanagement AT sarayoung maternalraceandclinicalvigilanceinobstetrichemorrhagemanagement AT swethatummala maternalraceandclinicalvigilanceinobstetrichemorrhagemanagement AT lindseyclaus maternalraceandclinicalvigilanceinobstetrichemorrhagemanagement AT ronaldiverson maternalraceandclinicalvigilanceinobstetrichemorrhagemanagement AT ashleycomfort maternalraceandclinicalvigilanceinobstetrichemorrhagemanagement AT christinadyarrington maternalraceandclinicalvigilanceinobstetrichemorrhagemanagement |